Alcon, Inc. Independent Director Committee Responds to Notice of Alcon EGM to Put Forth Novartis-Designated Director Candidates

HUENENBERG, Switzerland--(BUSINESS WIRE)--The Alcon Independent Director Committee (the “IDC”) notes that the recently announced extraordinary general meeting of Alcon shareholders, to be held August 16th, at which Novartis AG (“Novartis”) will put forth five candidates for the Alcon board of directors to replace the five members currently designated by Nestlé SA (“Nestlé”), was mandated under the Purchase and Option Agreement and the Shareholders Agreement entered into by Nestlé and Novartis on April 6, 2008. The shareholder meeting is a necessary and expected step in the consummation of those agreements.

Back to news